Vîslă Andreea, Probst Greta Helene, Flückiger Christoph
University of Zurich, Zurich, Switzerland.
University of Kassel, Kassel, Germany.
Clin Psychol Psychother. 2023 Jul-Aug;30(4):907-912. doi: 10.1002/cpp.2847. Epub 2023 Mar 16.
Meta-analytic research shows early response to psychotherapy to predict depression and anxiety outcomes posttreatment. However, little is known about which variables explain differences in early response. Moreover, for patients with generalized anxiety disorder (GAD), there is limited research on whether early response predicts longer-term changes in symptoms. In this study, we used anxiety and controllability beliefs assessed in daily life at intake to predict early response to treatment (until session 5), and we further examined if early response predicts longer-term changes in symptoms (until posttreatment, when adjusting for intake symptom severity) in patients with GAD.
Forty-nine individuals with GAD reported their anxiety and controllability beliefs using event-based (participant-initiated) ecological momentary assessment (EMA) for 7 days at intake. Symptoms were measured at pretreatment, session 5, session 10, and posttreatment.
Results show anxiety levels reported during EMA to be associated with a higher reduction in both anxiety and depressive symptoms early in treatment. Moreover, higher controllability beliefs during EMA were associated with less early response. When predicting change in symptoms until posttreatment, results showed an early change to significantly predict change in symptoms until posttreatment.
Given that we found early response to psychotherapy in patients with GAD to be a prognostic factor for long-term response, it is recommended to monitor response early in treatment and pay special attention to those patients showing less early response.
荟萃分析研究表明,心理治疗的早期反应可预测治疗后抑郁和焦虑的结果。然而,对于哪些变量可解释早期反应的差异,我们知之甚少。此外,对于广泛性焦虑症(GAD)患者,关于早期反应是否能预测症状的长期变化的研究有限。在本研究中,我们使用治疗开始时在日常生活中评估的焦虑和可控性信念来预测对治疗的早期反应(直至第5次治疗),并进一步研究早期反应是否能预测GAD患者症状的长期变化(直至治疗后,同时调整治疗开始时的症状严重程度)。
49名GAD患者在治疗开始时使用基于事件(参与者发起)的生态瞬时评估(EMA),连续7天报告他们的焦虑和可控性信念。在治疗前、第5次治疗、第10次治疗和治疗后测量症状。
结果显示,EMA期间报告的焦虑水平与治疗早期焦虑和抑郁症状的更大程度减轻相关。此外,EMA期间更高的可控性信念与早期反应较少相关。在预测直至治疗后的症状变化时,结果显示早期变化能显著预测直至治疗后的症状变化。
鉴于我们发现GAD患者对心理治疗的早期反应是长期反应的一个预后因素,建议在治疗早期监测反应,并特别关注那些早期反应较少的患者。